Last Updated: August 9, 2026

Details for Patent: 10,617,638

Name: Drug Patent Intelligence for US Patent 10617638
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 10,617,638 protect, and when does it expire?

Patent 10,617,638 protects TRIMBOW and is included in one NDA.

This patent has forty-nine patent family members in thirty-five countries.

Summary for Patent: 10,617,638

Title:	Stable pressurized aerosol solution composition of glycopyrronium bromide and formoterol combination
Abstract:	Aerosol solution compositions intended for use with a pressurized metered dose inhaler, comprising glycopyrronium bromide and formoterol, or a salt thereof or a solvate of said salt, optionally in combination with one or more additional active ingredients, and stabilized by a selected amount of a mineral acid, exhibit improved stability when contained in a can internally coated by a resin comprising a fluorinated ethylene propylene (FEP) polymer.
Inventor(s):	Sauro BONELLI, Diego COPELLI, Massimiliano Dagli Alberi, Francesca Usberti, Enrico Zambelli
Assignee:	Chiesi Farmaceutici SpA
Application Number:	US15/196,318
Patent Claim Types: see list of patent claims	Use; Composition; Formulation;
Patent landscape, scope, and claims:	error: insufficient information More… ↓ ⤷ Start Trial

Drugs Protected by US Patent 10,617,638

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Chiesi	TRIMBOW	beclomethasone dipropionate; formoterol fumarate; glycopyrrolate	AEROSOL, METERED;INHALATION	219622-001	May 14, 2026		RX	Yes	Yes	⤷ Start Trial	⤷ Start Trial	Y			MAINTENANCE TREATMENT OF ASTHMA	⤷ Start Trial
Chiesi	TRIMBOW	beclomethasone dipropionate; formoterol fumarate; glycopyrrolate	AEROSOL, METERED;INHALATION	219622-002	May 14, 2026		RX	Yes	Yes	⤷ Start Trial	⤷ Start Trial	Y			MAINTENANCE TREATMENT OF ASTHMA	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 10,617,638

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	3089735	⤷ Start Trial	C03089735/01	Switzerland	⤷ Start Trial
Argentina	098982	⤷ Start Trial
Argentina	130239	⤷ Start Trial
Australia	2014375301	⤷ Start Trial
Brazil	112016014583	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.